ContractJoint Development and License Agreement • November 2nd, 2007 • Palomar Medical Technologies Inc • Electromedical & electrotherapeutic apparatus
Third Amendment to the September 7, 2004 Joint Development and License Agreement Between Palomar Medical Technologies, Inc. and Johnson & Johnson Consumer Companies, Inc. (the “Agreement”) Whereas, pursuant to the Agreement, the parties are engaged in a collaboration to develop, clinically test and potentially commercialize home-use, light-based devices for (i) reducing or reshaping body fat including cellulite; (ii) reducing appearance of skin aging; and (iii) reducing or preventing acne; and Whereas, the parties desire to **. Now, Therefore, in consideration of the foregoing premises, the mutual promises and covenants of the parties contained herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows effective this 15th day of August 2007: 1. **.
ContractLease • November 2nd, 2007 • Palomar Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • Northland
THIRD AMENDMENT TO LEASE This Third Amendment to Lease is made and entered into as of the 30th day of July, 2007 by and between Northland Cambridge Street LLC , successor-in-interest to 80 Cambridge Street, LLC (“Landlord”) and Palomar Medical Technologies, Inc. (“Tenant”). WHEREAS, Landlord and Tenant are parties to that certain Commercial Lease dated June 17, 1999, as amended by First Amendment to Lease dated as of March 20, 2000 and by Second Amendment to Lease dated as of January 18, 2006 (collectively, the “Lease”), with respect to certain premises consisting of approximately 55,450 rentable square feet (the “82 Cambridge Street Premises”) in, and comprising the entire rentable area of, the building located at and known as 82 Cambridge Street, Burlington, Massachusetts; WHEREAS, Tenant desires to lease the entire rentable area of the building owned by Landlord and located at and known as 80 Cambridge Street, Burlington, Massachusetts (the “80 Cambridge Street Building”); and WHERE
ContractJoint Development and License Agreement • November 2nd, 2007 • Palomar Medical Technologies Inc • Electromedical & electrotherapeutic apparatus
Fourth Amendment to the September 7, 2004 Joint Development and License Agreement Between Palomar Medical Technologies, Inc. and Johnson & Johnson Consumer Companies, Inc. (the “Agreement”) Whereas, pursuant to the Agreement, the parties are engaged in a collaboration to develop, clinically test and potentially commercialize home-use, light-based devices for (i) reducing or reshaping body fat including cellulite; (ii) reducing appearance of skin aging; and (iii) reducing or preventing acne; and Whereas, the parties desire to modify certain provisions of the Agreement in order to **; and Whereas, the parties desire to modify certain provisions of the Agreement in order to Allow JJC to terminate the Agreement during the Optimization Period. Now, Therefore, in consideration of the foregoing premises, the mutual promises and covenants of the parties contained herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto,
